No. 19A886
Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc.
Tags: None
Latest Conference:
N/A
Question presented not available.
Docket Entries
2020-02-14
The order heretofore issued by The Chief Justice on February 10, 2020, is vacated. The application for a stay is, in all respects, denied.
2020-02-14
Reply of applicant Sanofi-Aventis Deutschland GmbH filed.
2020-02-13
Response to application from respondent Mylan Pharmaceuticals Inc. filed.
2020-02-10
UPON CONSIDERATION of the application of counsel for the applicant,
IT IS ORDERED that the mandate of the United States Court of Appeals for the Federal Circuit, case Nos. 2019-1368 and 2019-1369, is hereby stayed pending receipt of a response, due on or before Thursday, February 13, 2020, by 4:30 p.m. ET, and further order of the undersigned or of the Court.
2020-02-07
Application (19A886) for a stay, submitted to The Chief Justice.
Attorneys
Mylan Pharmaceuticals Inc.
Douglas H Carsten — Wilson Sonsini Goodrich & Rosati, Respondent
Sanofi-Aventis Deutschland GmbH
Adam Baker Banks — Weil, Gotshal & Manges LLP, Petitioner